This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (172)

Published on in Vol 9, No 11 (2020): November

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17735, first published .
Injectable Amoxicillin Versus Injectable Ampicillin Plus Gentamicin in the Treatment of Severe Pneumonia in Children Aged 2 to 59 Months: Protocol for an Open-Label Randomized Controlled Trial

Injectable Amoxicillin Versus Injectable Ampicillin Plus Gentamicin in the Treatment of Severe Pneumonia in Children Aged 2 to 59 Months: Protocol for an Open-Label Randomized Controlled Trial

Injectable Amoxicillin Versus Injectable Ampicillin Plus Gentamicin in the Treatment of Severe Pneumonia in Children Aged 2 to 59 Months: Protocol for an Open-Label Randomized Controlled Trial

Authors of this article:

Lubaba Shahrin1 Author Orcid Image ;   Mohammod Jobayer Chisti1 Author Orcid Image ;   Abu Sadat Mohammad Sayeem Bin Shahid1 Author Orcid Image ;   Abu Sayem Mirza Mohammad Hasibur Rahman1 Author Orcid Image ;   Md. Zahidul Islam1 Author Orcid Image ;   Farzana Afroze1 Author Orcid Image ;   Sayeeda Huq1 Author Orcid Image ;   Tahmeed Ahmed1 Author Orcid Image
Article Authors Cited by (4) Tweetations (1) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.